Aclarion announced the immediate termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets on January 3, 2025. The agreement, originally established on September 24, 2024, had permitted the company to sell common stock with an aggregate offering price of up to $10 million through an "at the market offering" program.During the agreement's term, Aclarion sold 1,606,211 shares of its common stock, generating approximately $0.3 million in gross proceeds. With this termination, the "at the market" offering facility under the Sales Agreement is no longer available for use.

Aclarion announced the immediate termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets on January 3, 2025. The agreement, originally established on September 24, 2024, had permitted the company to sell common stock with an aggregate offering price of up to $10 million through an "at the market offering" program.During the agreement's term, Aclarion sold 1,606,211 shares of its common stock, generating approximately $0.3 million in gross proceeds. With this termination, the "at the market" offering facility under the Sales Agreement is no longer available for use.